Journal of Pathology, Communicable Diseases and Preventive Medicines

Authors: Saurabh Bhilare, Sayali Chavan, Pooja Kadam, Vivekkumar Redasani

Abstract: Movement disorders include conditions like Parkinson's disease (PD). It occurs when the brain's nerve cells don't create enough dopamine, a neurotransmitter. Environmental chemical exposure may be a factor. People with the condition may experience difficulty walking, communicating, or performing basic tasks as their symptoms worsen. Since PD cannot be diagnosed with a lab test, diagnosis might be challenging. To diagnose it, medical professionals look at neurological symptoms and medical history. The field of PD management is expanding and aims to develop both novel and enhanced treatment approaches. Physicians can now treat patient-specific issues as they emerge in addition to the primary motor symptoms of Parkinson's disease (PD) thanks to pharmaceutical, surgical, and therapy interventions. This review addresses the current and established options for treating Parkinson's disease (PD) that can offer patient-specific care and lessen adverse effects from standard medicines.

Keywords: Parkinson’s disease, Epidemiology, Diagnosis, Parkinson’s treatment